做中國老百姓吃得起的好藥
貝達(dá)藥業(yè)開拓創(chuàng)新、造福于民,致力于通過新藥研發(fā),努力實現(xiàn)創(chuàng)新為民、科技惠民,為中國百姓做更多吃得起的好藥。
凱美納三期ICOGEN研究
2016-03-02
Reprint
隨機、雙盲、非劣效設(shè)計、評價埃克替尼和吉非替尼治療既往化療失敗的局部晚期或轉(zhuǎn)移的非小細(xì)胞肺癌患者的療效和安全性III期臨床試驗
Yuankai Shi, Li Zhang, Xiaoqing Liu, Caicun Zhou, Li Zhang,Shucai Zhang, Dong Wang, Qiang Li, Shukui Qin, Chunhong Hu,Yiping Zhang, Jianhua Chen, Ying Cheng, Jifeng Feng,Helong Zhang, Yong Song, Yi-Long Wu, Nong Xu, Jianying Zhou,Rongcheng Luo, Chunxue Bai, Yening Jin, Wenchao Liu,Zhaohui Wei, Fenlai Tan, Yinxiang Wang, Lieming Ding, Hong Dai,Shunchang Jiao, Jie Wang, Li Liang, Weimin Zhang, Yan SunLancet Oncol 2013; 14: 953–61